We use cookies to improve your online experience. By continuing to use our website we assume you are happy to allow the use of these cookies. Take a look at our Cookie Policy to learn more.

ACCELERATOR INCUBATOR
OF FONDAZIONE GOLINELLI

THE COMPLETE LIST OF THE STARTUPS SELECTED FOR "I-TECH INNOVATION 2021" IS AVAILABLE!

Discover more
8

months of acceleration

50+

mentors involved

1.000.000€

of investments

7

teams selected

G-FACTOR

G-Factor is a reactive environment whose aim is to support new entrepreneurs and researchers with high entrepreneurial potential to become companies able to successfully establish themselves in the market, creating replicable and scalable models. Three years after its establishment, G-Factor has consolidated its position as an accelerator for start-ups in the life sciences sector, while opening up to other vertical sectors.

We invest in innovative start-ups and teams by providing capital and expertise because we believe that the mix of finance and training is crucial to entrepreneurial success.

Read moreMOSTRA MENO

I-Tech Innovation Programme 2021 Download report

I-Tech Innovation 2021 is the new programme promoted by Fondazione Golinelli and CRIF. In the previous two editions, 15 start-ups in the Life Sciences sector were funded and accelerated, selected from over 250 applications with an investment of €1,625,000. Thanks to the partnership between the Fondazione and CRIF, G-Factor is now inaugurating two new verticals: FinTech & InsureTech and AgriTech & FoodTech, in addition to Life Sciences & Digital Health.

The 2021 Call, with an investment budget of €1,000,000, aims to select the next batch of 7 start-ups of which:

The call was open to all researchers, independent teams and start-ups that wish to turn their projects into an entrepreneurial reality. Selected teams will have access to G-Force 2021, the customised Acceleration Programme offering investment, mentoring and business networking.

Follow this link to read the article about the 3 selected startups for Life Sciences & Digital Health.

Follow this link to read the article about the 4 selected startups for Fintech & insurtech and Foodtech & Agritech.

Roadmap

Upcoming G-Factor Events

ONLINE EDITION
GRATUITO
Thursday 16 Dec 2021 ore 17:30
WHAT’S NEXT? IL PRIMO PRIMO PASSO VERSO UNA COMMUNITY DEDICATA ALLE STARTUP
Fondazione Golinelli, per il tramite del suo acceleratore G-Factor, e CRIF, sono pronte a supportare la costruzione di una community dedicata alle startup. Il 16 dicembre, dalle 17.30 alle 18.30, si svolgerà online What’s Next?, il primo passo verso questo obiettivo; un evento anteprima su opportunità, formazione e nuovi servizi, rivolti alle startup, in partenza da gennaio 2022. Ospite speciale: Ilan Misano con un intervento sull'ecosistema dell’innovazione Israeliano

image Evento
image Impresa
See all

G-FORCE

An innovative Acceleration Programme tailored to entrepreneurs in the Life Sciences, Fintech & Insuretech and Agritech sectors. The programme aims to accelerate the most talented teams with a high degree of innovation and a relevant technical-scientific profile, with special focus on the business dimension.

G-Force has a total duration of eight months.

For the first three months, the acceleration foresees intensive training and daily mentoring activities, with a mixed formula between remote and residential modes; for the following five months, follow-up activities with remote mentoring one day a week are foreseen.

The 2021 acceleration itinerary is tailor-made for the three specialisation areas of the start-ups that will be selected. The programme includes face-to-face webinars, workshops, mentoring and coaching tailored to each business project, concerning all strategic issues for business development. In the second part of the programme, ad-hoc networking events are foreseen to allow new start-ups and potential industrial partners and investors to meet and create connections.

WELCOME KIT

  • Access to a network of highly qualified mentors and partners
  • Access to a network of investors
  • Legal and patent support
  • Regulatory advice
  • Media Coverage & Communications
  • Accomodation for residential phase (when covid-19 emergency will be end)

Network

We collaborate with dozens of entrepreneurs, teachers and managers with different specializations and professional backgrounds to cover all the needs of accelerated startups: from product development to business storytelling, from IP to negotiation, from hard skills to soft skills.

Our industrial partners are important international players in the world of life sciences operating in different business areas: from pharmaceutical to medical devices, from biotech to data science. Together with our industrial partners we help startups to create sustainable and scalable businesses.

Alfasigma
CHIESI
Dompé
IQVIA Italia
B. Braun Avitum Italy
E-Novia
SIFI
Jacobacci & Partners
Bugnion
Gianni & Origoni
PQE
Previous Next
Alfasigma
CHIESI
Dompé
IQVIA Italia
B. Braun Avitum Italy
E-Novia
SIFI
Jacobacci & Partners
Bugnion
Gianni & Origoni
PQE
Previous Next

Our network is enriched by the presence of research centers, startups, companies and universities that make innovation their daily mission.

Invitalia
InnovUp
Arter
Iner
ClustEr Health
IIT
CNR - Istituto di Farmacologia Traslazionale
Fondazione ANT
Previous Next
Invitalia
InnovUp
Arter
Iner
ClustEr Health
IIT
CNR - Istituto di Farmacologia Traslazionale
Fondazione ANT
Previous Next

We work together with some of the main Italian institutions to accompany our startups on their growth path.

A11vENTURE
BacktoWork24
Banca di Bologna
DoorWay
OCC, Overseas Capital Contest
IBAN - ITALIAN BUSINESS ANGEL NETWORK
Indaco Venture Partners SGR
Mamacrowd - Siamo Soci
Panakes Partners
Unicredit Start Labs
Vertis
Previous Next
A11vENTURE
BacktoWork24
Banca di Bologna
DoorWay
OCC, Overseas Capital Contest
IBAN - ITALIAN BUSINESS ANGEL NETWORK
Indaco Venture Partners SGR
Mamacrowd - Siamo Soci
Panakes Partners
Unicredit Start Labs
Vertis
Previous Next

Startups

124 applications have been received for the first call of G-Factor, Life Sciences Innovation : 30 of these have reached the final stage and 10 have been selected to participate in the acceleration process which has end in December 2019 with the awaited Investor Day. Each Startup has received an investment of €100,000 €

medtech

BCI deals with the biocompatibility of cardiac valve substitutes manufactured with animal tissues, improving their performance and doubling their durability.

Website
medtech

Adam's Hand is a myoelectric hand prosthesis. A single motor allows you to move all your fingers, automatically adapting them to the shape and size of the objects being handled

Website
bioengineering

Complexdata has developed a platform that uses artificial intelligence to estimate the risk of metastasis in cancer patients.

Website
medtech

Diamante specializes in the production of nanoparticles for the diagnosis of autoimmune diseases through the exploitation of plants as compounds with high added value.

Website
bioengineering

eVAI is cloud platform developed by enGenome to support geneticists in the diagnosis of hereditary diseases from NGS data.

Website
medtech

Genoa Instruments, will produce high-tech scientific instruments in the field of super-resolution optical microscopy.

Website
medtech

Holey has created a solution capable of producing custom-made 3D printable orthopedic braces, which can replace both traditional plaster and commercial braces.

Website
medtech

MgShell developed a solution to treat maculopathy capable of timing the drug release, therefore reducing the therapeutic load from several injections to a single injection.

medtech

P4P produces innovative polymeric biomaterials processed with additive manufacturing techniques to obtain advanced systems for the personalized administration of drugs.

medtech

RELIEF has created a minimally invasive endourethral device that can be inserted into the urethra of patients with severe incontinence and can be activated with a small magnet.

137 applications have been received for the second call of G-Factor, Life Sciences Innovation 2020: 24 of these have reached the final stage and 5 have been selected to participate in the acceleration process which will end in December 2020 with the awaited Investor Day. Each Startup will receive an investment of €125,000 of which € 90,000 of liquidity and € 35,000 in kinds.

nutraceutica

Thanks to a patented biotechnology, Bacfarm produces deinoxanthin, the most powerful antioxidant among carotenoids and UV shield.

Website
medtech

Innovative and unique CTC single cell blood analysis, disposable microfluidic analysis device, single cell analysis, image sorting and archiving.

Website
medtech

An innovative biosensor for prostate cancer to reduce the number of unnecessary tests, costs, waiting times and inconvenience for the patient.

Website
pharma

Micro-ReSkin is a PerFormS product developed to meet the needs of patients with acute, or chronic skin inflammations such as psoriasis.

Website
medtech

RECORNEA has developed a revolutionary solution. With a single device and in a single step it managed to improve her eyesight and stop the progression of the keratoconus.

Website

209 applications received for the I-Tech Innovation Program call launched by Fondazione Golinelli and CRIF in three areas: Life Sciences/Digital Health (3 startups selected), Fintech/Insurtech (2 startups selected), and FoodTech/Agritech (2 startups selected). 1 million euros will be granted for the startups themselves

Lifescience/Digital health

created with the aim of experimenting a new compound called DDC#1 on humans for Acute Myeloid Leukemia and COVID-19 fighting

Lifescience/Digital health

goes to market through a device that makes the medicines’ selection process faster and more effective through the laboratory plastic creation of an environment that looks like the tissues of the human body and indeed similar to the context in which the medicine will work

Lifescience/Digital health

is based on the use of polymeric retinal prostheses for vision recovery, subsequent to a loss due to retinal degeneration induced by several diseases (i.e. retinitis pigmentosa).

Fintech/Insurtech

EvenFi is the crowdlending platform that offers investors the opportunity to earn by investing in growth projects of startups and SMEs.

Website
Fintech/Insurtech

allows consumers to choose and select the innovative financial services that best comply with their needs. Its services let suppliers access a single distribution channel that guarantees them to contain acquisition costs.

Website
Foodtech/Agritech

is the first virtual agricultural community based on two pillars: small producers and final consumers. It is also a marketplace for direct sales of agricultural products.

Website
Foodtech/Agritech

is a unified data analysis platform that is fully automated and able to extract information from satellite images. By removing the technological barriers in the use of satellite data, the platform allows to transform satellite images into geospatial information by offering data the farmer needs in the simplest way to read them.

Website

medtech

BCI deals with the biocompatibility of cardiac valve substitutes manufactured with animal tissues, improving their performance and doubling their durability.

Sito web
medtech

Adam's Hand is a myoelectric hand prosthesis. A single motor allows you to move all your fingers, automatically adapting them to the shape and size of the objects being handled

Sito web
bioengineering

Complexdata has developed a platform that uses artificial intelligence to estimate the risk of metastasis in cancer patients.

Sito web
medtech

Diamante specializes in the production of nanoparticles for the diagnosis of autoimmune diseases through the exploitation of plants as compounds with high added value.

Sito web
bioengineering

eVAI is cloud platform developed by enGenome to support geneticists in the diagnosis of hereditary diseases from NGS data.

Sito web
medtech

Genoa Instruments, will produce high-tech scientific instruments in the field of super-resolution optical microscopy.

Sito web
medtech

Holey has created a solution capable of producing custom-made 3D printable orthopedic braces, which can replace both traditional plaster and commercial braces.

Sito web
medtech

MgShell developed a solution to treat maculopathy capable of timing the drug release, therefore reducing the therapeutic load from several injections to a single injection.

medtech

P4P produces innovative polymeric biomaterials processed with additive manufacturing techniques to obtain advanced systems for the personalized administration of drugs.

medtech

RELIEF has created a minimally invasive endourethral device that can be inserted into the urethra of patients with severe incontinence and can be activated with a small magnet.

nutraceutica

Thanks to a patented biotechnology, Bacfarm produces deinoxanthin, the most powerful antioxidant among carotenoids and UV shield.

Sito web
medtech

Innovative and unique CTC single cell blood analysis, disposable microfluidic analysis device, single cell analysis, image sorting and archiving.

Sito web
medtech

An innovative biosensor for prostate cancer to reduce the number of unnecessary tests, costs, waiting times and inconvenience for the patient.

Sito web
pharma

Micro-ReSkin is a PerFormS product developed to meet the needs of patients with acute, or chronic skin inflammations such as psoriasis.

Sito web
medtech

RECORNEA has developed a revolutionary solution. With a single device and in a single step it managed to improve her eyesight and stop the progression of the keratoconus.

Sito web
lifescience

created with the aim of experimenting a new compound called DDC#1 on humans for Acute Myeloid Leukemia and COVID-19 fighting

lifescience

goes to market through a device that makes the medicines’ selection process faster and more effective through the laboratory plastic creation of an environment that looks like the tissues of the human body and indeed similar to the context in which the medicine will work

lifescience

is based on the use of polymeric retinal prostheses for vision recovery, subsequent to a loss due to retinal degeneration induced by several diseases (i.e. retinitis pigmentosa).

fintech

EvenFi is the crowdlending platform that offers investors the opportunity to earn by investing in growth projects of startups and SMEs.

Sito web
fintech

allows consumers to choose and select the innovative financial services that best comply with their needs. Its services let suppliers access a single distribution channel that guarantees them to contain acquisition costs.

Sito web
agritech

is the first virtual agricultural community based on two pillars: small producers and final consumers. It is also a marketplace for direct sales of agricultural products.

Sito web
agritech

is a unified data analysis platform that is fully automated and able to extract information from satellite images. By removing the technological barriers in the use of satellite data, the platform allows to transform satellite images into geospatial information by offering data the farmer needs in the simplest way to read them.

Sito web

Team

Antonio Danieli

Vice President, Director General and Board Member
@ Fondazione Golinelli
CEO @ G-Factor Incubator-Accelerator

Antonio Falcone

Advisor scale-up startup

Benedetta D’Oria

Head of Administration

b.doria@fondazionegolinelli.it
Silvia Maltoni

Head of G-Factor Startup Development and open innovation projects

s.maltoni@fondazionegolinelli.it
Silvia Cozzi

Program Manager

s.cozzi@fondazionegolinelli.it
Francesca Cortelazzo

Program Manager

f.cortellazzo@fondazionegolinelli.it
Giulia Mastandrea

Junior Project Manager

g.mastandrea@fondazionegolinelli.it
Francesco Castellana

Communication Manager

f.castellana@fondazionegolinelli.it

Subscribe to our newsletter

Be the first to get news and updates on our programs and events

Contact Us

How can we help you?